Detection of carcinogenic and modifying potentials by test compounds using a mouse lung carcinogenesis bioassay

Journal of Toxicologic Pathology

Volumn 20, Issue 3, 2007, Pages 117-123

  Imaida, Katsumi ^a   Yokohira, Masanao ^a   Kuno, Toshiya ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Bioassay; Carcinogen; Chemoprevention; Lung carcinogenesis; Mouse; Promoter

Indexed keywords

EID: 35548973088     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.20.117     Document Type: Review

References (70)

1. Wagenaar SS and Tazelaar HD. Ten years after the WHO classification for lung cancer: where are we? Lung Cancer. 11 Suppl 3: S39-43. 1994.
2. Ito N, Imaida K, Asamoto M, and Shirai T. Early detection of carcinogenic substances and modifiers in rats. Mutat Res. 462: 209-217. 2000.
3. Ito N, Hasegawa R, Imaida K, Hirose M, and Shirai T. Medium-term liver and multi-organ carcinogenesis bioassays for carcinogens and chemopreventive agents. Exp Toxicol Pathol. 48: 113-119. 1996.
4. Tatematsu M, Nozaki K, and Tsukamoto T. Helicobacter pylori infection and gastric carcinogenesis in animal models. Gastric Cancer. 6: 1-7. 2003.
5. Imaida K, Fukushima S, Shirai T, Masui T, Ogiso T, and Ito N. Promoting activities of butylated hydroxyanisole, butylated hydroxytoluene and sodium L-ascorbate on forestomach and urinary bladder carcinogenesis initiated with methylnitrosourea in F344 male rats. Gann. 75: 769-775. 1984.
6. Fukushima S, Imaida K, Sakata T, Okamura T, Shibata M, and Ito N. Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats. Cancer Res. 43: 4454-4457. 1983.
7. Sugimura T. Nutrition and dietary carcinogens. Carcinogenesis. 21: 387-395. 2000.
8. Binukumar B and Mathew A. Dietary fat and risk of breast cancer. World J Surg Oncol. 3: 45. 2005.
9. Ramon JM, Bou R, Romea S, Alkiza ME, Jacas M, Ribes J, and Oromi J. Dietary fat intake and prostate cancer risk: a case-control study in Spain. Cancer Causes Control. 11: 679-685. 2000.
10. Smith-Warner SA, Ritz J, Hunter DJ, Albanes D, Beeson WL, van den Brandt PA, Colditz G, Folsom AR, Fraser GE, Freudenheim JL, Giovannucci E, Goldbohm RA, Graham S, Kushi LH, Miller AB, Rohan TE, Speizer FE, Virtamo J, and Willett WC. Dietary fat and risk of lung cancer in a pooled analysis of prospective studies. Cancer Epidemiol Biomarkers Prev. 11: 987-992. 2002.
11. Kallianpur AR, Lee SA, Gao YT, Lu W, Zheng Y, Ruan ZX, Dai Q, Gu K, Shu XO, and Zheng W. Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study. Breast Cancer Res Treat. 2007 (in press).
12. Rogers AE, Sullivan LM, and Hafer LJ. Dietary fat, body weight, and cancer: contributions of studies in rodents to understanding these cancer risk factors in humans. Toxicol Sci. 52: 66-71. 1999.
13. Snyderwine EG. Diet and mammary gland carcinogenesis. Recent Results Cancer Res. 152: 3-10. 1998.
14. Weisburger JH. Dietary fat and risk of chronic disease: mechanistic insights from experimental studies. J Am Diet Assoc. 97: S16-23. 1997.
15. Reddy BS. Nutritional factors and colon cancer. Crit Rev Food Sci Nutr. 35: 175-190. 1995.
16. Shirai T, Asamoto M, Takahashi S, and Imaida K. Diet and prostate cancer. Toxicology. 181-182: 89-94. 2002.
17. Reddy BS. Role of dietary fiber in colon cancer: an overview. Am J Med. 106: 16S-19S; discussion 50S-51S. 1999.
18. Chowdhury P, Nishikawa M, Blevins GW, Jr., and Rayford PL. Response of rat exocrine pancreas to high-fat and high-carbohydrate diets. Proc Soc Exp Biol Med. 223: 310-315. 2000.
19. Shirai T, Masuda A, Hirose M, Ikawa E, and Ito N. Enhancement of N-bis(2-hydroxypropyl)nitrosamine-initiated lung tumor development in rats by bleomycin and N-methyl-N-nitrosourethane. Cancer Lett. 25: 25-31. 1984.
20. Witschi HP. Enhancement of tumor formation in mouse lung by dietary butylated hydroxytoluene. Toxicology. 21: 95-104. 1981.
21. Witschi HR and Doherty DG. Butylated hydroxyanisole and lung tumor development in A/J mice. Fundam Appl Toxicol. 4: 795-801. 1984.
22. Witschi HP, Hakkinen PJ, and Kebrer JP. Modification of lung tumor development in A/J mice. Toxicology. 21: 37-45. 1981.
23. Yano T and Ichikawa T. The effect of glycerol and 4-nitroquinoline 1-oxide on active oxygen formation in subcellular fractions of lung tissue. Biochem Pharmacol. 43: 2658-2660. 1992.
24. Inayama Y. Promoting action of glycerol in pulmonary tumorigenesis model using a single administration of 4-nitroquinoline 1-oxide in mice. Jpn J Cancer Res. 77: 345-350. 1986.
25. Yano T, Obata Y, Ishikawa G, and Ichikawa T. Enhancing effect of high dietary iron on lung tumorigenesis in mice. Cancer Lett. 76: 57-62. 1994.
26. Imaida K, Sato H, Okamiya H, Takahashi M, and Hayashi Y. Enhancing effect of high fat diet on 4-nitroquinoline 1-oxide-induced pulmonary tumorigenesis in ICR male mice. Jpn J Cancer Res. 80: 499-502. 1989.
27. Beems RB and van Beek L. Modifying effect of dietary fat on benzo[a]pyrene-induced respiratory tract tumours in hamsters. Carcinogenesis. 5: 413-417. 1984.
28. Pour PM and Birt DF. Effect of dietary protein on N-nitrosobis(2-oxopropyl)amine-induced carcinogenesis and on spontaneous diseases in Syrian golden hamsters. J Natl Cancer Inst. 76: 67-72. 1986.
29. Ohgaki H, Hasegawa H, Suenaga M, Sato S, Takayama S, and Sugimura T. Carcinogenicity in mice of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) from cooked foods. Carcinogenesis. 8: 665-668. 1987.
30. Sinha R, Kulldorff M, Swanson CA, Curtin J, Brownson RC, and Alavanja MC. Dietary heterocyclic amines and the risk of lung cancer among Missouri women. Cancer Res. 60: 3753-3756. 2000.
31. Dontenwill W, Chevalier HJ, Harke HP, Lafrenz U, Reckzeh G, and Schneider B. Investigations on the effects of chronic cigarette-smoke inhalation in Syrian golden hamsters. J Natl Cancer Inst. 51: 1781-1832. 1973.
32. Takahashi M, Imaida K, Mitsumori K, Okamiya H, Shinoda K, Yoshimura H, Furukawa F, and Hayashi Y. Promoting effects of cigarette smoke on the respiratory tract carcinogenesis of Syrian golden hamsters treated with diethylnitrosamine. Carcinogenesis. 13: 569-572. 1992.
33. Mauderly JL, Gigliotti AP, Barr EB, Bechtold WE, Belinsky SA, Hahn FF, Hobbs CA, March TH, Seilkop SK, and Finch GL. Chronic inhalation exposure to mainstream cigarette smoke increases lung and nasal tumor incidence in rats. Toxicol Sci. 81: 280-292. 2004.
34. Coggins CR. A review of chronic inhalation studies with mainstream cigarette smoke, in hamsters, dogs, and nonhuman primates. Toxicol Pathol. 29: 550-557. 2001.
35. Hutt JA, Vuillemenot BR, Barr EB, Grimes MJ, Hahn FF, Hobbs CH, March TH, Gigliotti AP, Seilkop SK, Finch GL, Mauderly JL, and Belinsky SA. Life-span inhalation exposure to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways. Carcinogenesis. 26: 1999-2009. 2005.
36. Hecht SS. Carcinogenicity studies of inhaled cigarette smoke in laboratory animals: old and new. Carcinogenesis. 26: 1488-1492. 2005.
37. Wingo PA, Ries LA, Giovino GA, Miller DS, Rosenberg HM, Shopland DR, Thun MJ, and Edwards BK. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst. 91: 675-690. 1999.
38. Witschi H. A/J mouse as a model for lung tumorigenesis caused by tobaeco smoke: strengths and weaknesses. Exp Lung Res. 31: 3-18. 2005.
39. Willemenot BR, Pulling LC, Palmisano WA, Hutt JA, and Belinsky SA. Carcinogen exposure differentially modulates RAR-beta promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis. Carcinogenesis. 25: 623-629. 2004.
40. Pulling LC, Vuillemenot BR, Hutt JA, Devereux TR, and Belinsky SA. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Cancer Res. 64: 3844-3848: 2004.
41. Bonner AE, Lemon WJ, Devereux TR, Lubet RA, and You M. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas. Oncogene. 23: 1166-1176. 2004.
42. Ahrendt SA, Decker PA, Alawi EA, Zhu Yr YR, Sanchez-Cespedes M, Yang SC, Haasler GB, Kajdacsy-Balla A, Demeure MJ, and Sidransky D. Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer. 92: 1525-1530. 2001.
43. Ton TV, Hong HH, Anna CH, Dunnick JK, Devereux TR, Sills RC, and Kim Y. Predominant K-ras codon 12 G → A transition in chemically induced lung neoplasms in B6C3F1 mice. Toxicol Pathol. 32: 16-21. 2004.
44. Fujieda M, Yamazaki H, Saito T, Kiyotani K, Gyamfi MA, Sakurai M, Dosaka-Akita H, Sawamura Y, Yokota J, Kunitoh H, and Kamataki T. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis. 25: 2451-2458. 2004.
45. Kamataki T, Fujieda M, Kiyotani K, Iwano S, and Kunitoh H. Genetic polymorphism of CYP2A6 as one of the potential determinants of tobacco-related cancer risk. Biochem Biophys Res Commun. 338: 306-310. 2005.
46. Topcu Z, Chiba I, Fujieda M, Shibata T, Ariyoshi N, Yamazaki H, Sevgican F, Muthumala M, Kobayashi H, and Kamataki T, CYP2A6 gene deletion reduces oral cancer risk in betel quid chewers in Sri Lanka. Carcinogenesis. 23: 595-598. 2002.
47. Belinsky SA, Devereux TR, Foley JF, Maronpot RR, and Anderson MW. Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res. 52: 3164-3173. 1992.
48. Takeuchi H, Saoo K, Yokohira M, Ikeda M, Maeta H, Miyazaki M, Yamazaki H, Kamataki T, and Imaida K. Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. Cancer Res. 63: 7581-7583. 2003.
49. Rehm S, Ward JM, and Sass B. Tumours of the Lungs. IARC Sci Publ. 325-355. 1994.
50. Takeuchi H, Saoo K, Matsuda Y, Yokohira M, Yamakawa K, Zeng Y, Miyazaki M, Fujieda M, Kamataki T, and Imaida K. Dose dependent inhibitory effects of dietary 8-methoxypsoralen on NNK-induced lung tumorigenesis in female A/J mice. Cancer Lett. 234: 232-238. 2006.
51. Lindberg R, Burkhart B, Ichikawa T, and Negishi M. The structure and characterization of type I P-450(15) alpha gene as major steroid 15 alpha-hydroxylase and its comparison with type II P-450(15) alpha gene. J Biol Chem. 264: 6465-6471. 1989.
52. Miyazaki M, Yamazaki H, Takeuchi H, Saoo K, Yokohira M, Masumura K, Nohmi T, Funae Y, Imaida K, and Kamataki T. Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas. Carcinogenesis. 26: 1947-1955. 2005.
53. Parkin DM, Bray F, Ferlay J, and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 55: 74-108. 2005.
54. Soria JC, Kim ES, Fayette J, Lantuejoul S, Deutsch E, and Hong WK. Chemoprevention of lung cancer. Lancet Oncol. 4: 659-669. 2003.
55. Vignot S, Spano JP, Lantuejoul S, Andre F, Le Chevalier T, and Soria JC. Chemoprevention of lung cancer. Recent Results Cancer Res. 166: 145-165. 2005.
56. Okada S, Tanaka K, Sato T, Ueno H, Saito S, Okusaka T, Sato K, Yamamoto S, and Kakizoe T. Dose-response trial of lactoferrin in patients with chronic hepatitis C. Jpn J Cancer Res. 93: 1063-1069. 2002.
57. Ishii K, Takamura N, Shinohara, M. Wakui, N. Shin H, Sumino Y, Ohmoto Y, Teraguchi S, and Yamauchi K. Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months. Hepatol Res. 25: 226-233. 2003.
58. Choe YH, Oh YJ, Lee NG, Imoto I, Adachi Y, Toyoda N, and Gabazza EC. Lactoferrin sequestration and its contribution to iron-deficiency anemia in Helicobacter pylori-infected gastric mucosa. J Gastroenterol Hepatol. 18: 980-985. 2003.
59. Dial EJ and Lichtenberger LM. Effect of lactoferrin on Helicobacter felis induced gastritis. Biochem Cell Biol. 80: 113-117. 2002.
60. Yang N, Stensen W, Svendsen JS, and Rekdal O. Enhanced antitumor activity and selectivity of lactoferrin-derived peptides. J Pept Res. 60: 187-197. 2002.
61. Vogel HJ, Schibli DJ, Jing W, Lohmeier-Vogel EM, Epand RF, and Epand RM. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Biochem Cell Biol. 80: 49-63. 2002.
62. Shimamura M, Yamamoto Y, Ashino H, Oikawa T, Hazato T, Tsuda H, and Iigo M. Bovine lactoferrin inhibits tumor-induced angiogenesis. Int J Cancer. 111: 111-116, 2004.
63. Tanaka T, Kawabata K, Kohno H, Honjo S, Murakami M, Ota T, and Tsuda H. Chemopreventive effect of bovine lactoferrin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats. Jpn J Cancer Res. 91: 25-33. 2000.
64. Masuda C, Wanibuchi H, Sekine K, Yano Y, Otani S, Kishimoto T, Tsuda H, and Fukushima S. Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis. Jpn J Cancer Res. 91: 582-588. 2000.
65. Ushida Y, Sekine K, Kuhara T, Takasuka N, Iigo M, and Tsuda H. Inhibitory effects of bovine lactoferrin on intestinal polyposis in the Apc(Min) mouse. Cancer Lett. 134: 141-145. 1998.
66. Tsuda H, Sekine K, Takasuka N, Toriyama-Baba H, and Iigo M. Prevention of colon carcinogenesis and carcinoma metastasis by orally administered bovine lactoferrin in animals. Biofactors. 12: 83-88. 2000.
67. Estensen RD, Jordan MM, Wiedmann TS, Galbraith AR, Steele VE, and Wattenberg LW. Effect of chemopreventive agents on separate stages of progression of benzo[alpha]pyrene induced lung tumors in A/J mice. Carcinogenesis. 25: 197-201. 2004.
68. Matsuda Y, Saoo K, Hosokawa K, Yamakawa K, Yokohira M, Zeng Y, Takeuohi H, and Imaida K. Post-initiation chemopreventive effects of dietary bovine lactoferrin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in female A/J mice. Cancer Lett. 246: 41-46. 2006.
69. Kohno H, Taima M, Sumida T, Azuma Y, Ogawa H, and Tanaka T. Inhibitory effect of mandarin juice rich in beta-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in mice. Cancer Lett. 174: 141-150. 2001.
70. Gown AM and Willingham MC. Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. J Histochem Cytochem. 50: 449-454. 2002.